S. Altrichter

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Martin Church

Visiting Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Katrine Baumann

Københavns Universitet

DENMARK

View details

Marcus Maurer

GERMANY

View details

Dorothea Terhorst-Molawi

Charité - Universitätsmedizin Berlin

GERMANY

View details

Laurent Reber

FRANCE

View details

Zsolt Szepfalusi

Medical University of Vienna

AUSTRIA

View details

Francesca Levi-Schaffer

ISRAEL

View details

Inge Kortekaas Krohn

Vrije Universiteit Brussel (VUB)

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

S. Altrichter

Research Interests

Explore related searches

Contact this professor

Articles (10)

Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria

Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases

One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2

Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndrome

Soluble IgE‐binding factors in the serum of food‐allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor

Development of the Cold Urticaria Activity Score

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience

Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions

Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response

Collaborators (8)

Martin Church

Katrine Baumann

Marcus Maurer

Dorothea Terhorst-Molawi

Laurent Reber

Zsolt Szepfalusi

Francesca Levi-Schaffer

Inge Kortekaas Krohn

Make your next move.